Chengdu Easton Biopharmaceuticals subsidiary Shuode Pharmaceutical passed the on-site inspection by the US FDA.
Yuandong Biology (688513.SH) announced that its wholly-owned subsidiary Chengdu Suode Pharmaceutical Co., Ltd. (referred to as "Suode Pharmaceutical") underwent current Good Manufacturing Practice (cGMP) inspections and Bioresearch Monitoring Program (BIMO) inspections by the U.S. Food and Drug Administration (FDA) from May 6 to 9, 2025 and from May 16 to 22, 2025, respectively, for the approval inspection of naloxone hydrochloride nasal spray. Recently, Suode Pharmaceutical received two Establishment Inspection Reports (EIR) issued by the U.S. FDA, and Suode Pharmaceutical passed the above-mentioned inspections with zero defects (no 483).
Chengdu Easton Biopharmaceuticals (688513.SH) announced that its wholly-owned subsidiary, Chengdu Shuode Pharmaceuticals Co., Ltd.(referred to as "Shuode Pharmaceuticals"), underwent Current Good Manufacturing Practice (cGMP) inspections and Bioresearch Monitoring (BIMO) inspections by the U.S. Food and Drug Administration (FDA) from May 6th to 9th and May 16th to 22nd, 2025. These inspections were conducted for the approval of naloxone hydrochloride nasal spray. Recently, Shuode Pharmaceuticals received two Establishment Inspection Reports (EIR) from the U.S. FDA, indicating that Shuode Pharmaceuticals passed both inspections with no deficiencies (no 483).
Related Articles
China Aluminum International Engineering Corporation (601068.SH)The consortium won the bid for the upgrade and renovation project of the electrolytic cell at the Qingtongxia Project by taking over the work of the previous contractor.
On November 27, ONEWO(02602) spent 16.4935 million Hong Kong dollars to repurchase 798,300 shares.
DEKON AGR (02419) spent 5.1775 million Hong Kong dollars to repurchase 69,700 shares on November 27th.
China Aluminum International Engineering Corporation (601068.SH)The consortium won the bid for the upgrade and renovation project of the electrolytic cell at the Qingtongxia Project by taking over the work of the previous contractor.
On November 27, ONEWO(02602) spent 16.4935 million Hong Kong dollars to repurchase 798,300 shares.
DEKON AGR (02419) spent 5.1775 million Hong Kong dollars to repurchase 69,700 shares on November 27th.
RECOMMEND
Food Delivery Ceasefire: Chinese Concept Stocks Reach Dual Inflection In Value And Technology — From Cash‑Burning Rivalry To An AI‑Led Strategic Upgrade
27/11/2025
Six Departments Issue Joint Plan To Boost Consumption And Improve Supply‑Demand Alignment For Consumer Goods
27/11/2025
Citi Research On China’s Humanoid Robot Industry: Broad Optimism, Exponential Growth Likely In 2026, At Least A Doubling
27/11/2025
